Table 2.

Clinical characteristics of patients with malignant TSFT

No	Age	Sex	Smoking	Symptoms	P/R	Tumor size (cm)	Treatment	RFS (months)	OS(months)
1	67	M	Never	None	P	16	Mass excision (R0)	118 +	118 +
2	63	F	Never	Cough	P	19	Neoadjuvant chemotherapy + mass excision with lung wedge resection (R0)	102 +	102 +
3	72	F	Never	Dyspnea	P	40	Mass excision with lobectomy (R0)	100 +	100 +
4	19	F	Never	Chest pain plus fever	P	13.5	Mass excision with pneumonectomy (R0)	95 +	95 +
5	69	F	Never	Dyspnea plus cough	P	11.5 18	1. Mass excision (R0) 2. Mass excision (R1) + radiotherapy	8	23
6	64	F	Never	None	P	14.5	Mass excision (R0)	63 +	63 +
7	51	F	Never	None	P	7	Mass excision (R0)	133 +	133 +
8	62	F	Never	Cough	P	10	Mass excision with lung wedge resection (R0)	26	27
9	43	F	Never	Dyspnea plus cough	P	18	1. Mass excision with pneumonectomy associated with partial diaphragm and repair (R0) + chemotherapy 2. radiotherapy	4	95 +
10	61	F	Never	Cough	R1	7	Mass excision with lung wedge resection plus partial pericardiectomy and parietal pleura resection (R2)	3	3
11	67	F	Never	None	R2	2 3.5	1. Mass excision with lung wedge resection (R0) + chemotherapy 2. Mass excision with lung wedge resection plus parietal pleura biopsy and pericardial nodules biopsy (R2)	13	15
12	58	M	Never	None	R2	1 7	1. Mass excision with lung wedge resection (R0) 2. Mass excision with partial costatectomy plus partial pericardiectomy and parietal pleura resection resection (R2)	66	71

Surgical margins were categorized as R0: clear (absence of tumor within 1 mm from the edge of the inked specimen); R1: microscopically positive; R2: grossly positive

P primary tumor, R¹ regional recurrent tumor, R² solitary lung metastasis